If your are 71, you might also be eligible (see below)
Studies show that Shingrix® vaccine reduces the risk of shingles by 90% and the risk of post-herpetic neuralgia by 88-91%. It is given in 2 doses, 2 to 6 months apart.
- Adults who previously purchased Zostavax®II are eligible for 2 doses of publicly funded Shingrix® vaccine.
- Adults, who received a dose of publicly funded Zostavax®II are not eligible for the publicly funded Shingrix® vaccine.
- Adults, who are turning 71 in 2020 or 2021, and missed getting vaccinated due to the COVID-19 pandemic, are eligible for 2-doses of Shingrix® until December 31, 2021.
- Shingrix® should be offered to eligible individuals regardless of their history of varicella infection, and can be given at the same time as other live or inactivated vaccines including unadjuvanted influenza vaccine.